Jarno Melenhorst

7PUBLICATIONS
46CO-AUTHORS
Sensory systemsSurgeryRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 22, 2024
Effectiveness, safety and cost-effectiveness of sacral neuromodulation for idiopathic slow-transit constipation: a systematic review.

Stella C M Heemskerk, Aart A van der Wilt, Bart M F Penninx

|Feb 22, 2023
Impact of the COVID-19 pandemic on surgical care in the Netherlands.

Michelle R de Graaff, Rianne N M Hogenbirk, Yester F Janssen

|Mar 08, 2022
Response to the comment on 'Selected stage IV rectal cancer patients managed by the watch-and-wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?'

Petra A Custers, Geerard L Beets, Jarno Melenhorst

|Jan 21, 2022
Selected stage IV rectal cancer patients managed by the watch-and-wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?

Petra A Custers, Britt J P Hupkens, Brechtje A Grotenhuis

|Jul 27, 2021
Burden of disease experienced by patients following a watch-and-wait policy for locally advanced rectal cancer: A qualitative study.

Alexander J Pennings, Merel L Kimman, Anke H C Gielen

|Aug 19, 2020
Sacral Neuromodulation for Lower Urinary Tract and Bowel Dysfunction in Animal Models: A Systematic Review With Focus on Stimulation Parameter Selection.

Perla Douven, Roman Assmann, Stephanie O Breukink

Pageof 2